India’s leading cancer medicine maker Dabur Pharma is on the lookout for overseas acquisitions, Mohit Burman, its newly appointed chairman, indicated.
In an exclusive interview, Burman, who took charge of Dabur Pharma on Thursday, told Business Standard that the change of guard, is in line with Dabur Group’s overall plan to engage the new-generation managerial heads throughout its business empire.
“The immediate thing to do is to chart a higher growth path by looking at global opportunities. Dabur Pharma is a speciality oncology company. It will continue to be so. Over the last 10 -15 years, we have established our credentials and have a global reputation,” he said.
Dabur’s acquisition of an over 14 per cent stake in Punjab Tractors and the acquisition of Balsara’s Home and Hygiene business were all driven by him. Burman is taking charge of Dabur Pharma at a stage when the company is consolidating its position in several South East Asian markets.
(Source: Business Standard)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment